Table 2.

Persistence of B19 IgG After BMT in Relation to Prior Recipient and Donor Immunity

B19 IgGProportion Seropositive at 2-3 yr Post-BMTYears Serum Received Post-BMT
Pre-BMTMedianRange
RecipientDonor
Group A − − 2/13 2-3 
Group B − 1/15 2-3 
Total   3/28* 
Group C − 10/16 2-3 
Group D 12/22 2-3.5 
Total   22/38* 
B19 IgGProportion Seropositive at 2-3 yr Post-BMTYears Serum Received Post-BMT
Pre-BMTMedianRange
RecipientDonor
Group A − − 2/13 2-3 
Group B − 1/15 2-3 
Total   3/28* 
Group C − 10/16 2-3 
Group D 12/22 2-3.5 
Total   22/38* 
*

Difference between these two proportions significant (P = .0003).

or Create an Account

Close Modal
Close Modal